Lexeo Therapeutics (NASDAQ:LXEO) just reported results for the second quarter of 2024.
- Lexeo Therapeutics reported earnings per share of -64 cents. This was above the analyst estimate for EPS of -79 cents.
- The company did not report any revenue for the quarter.